18-46560210-CTCCTCCTCT-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP3BP6
The NM_001384474.1(LOXHD1):c.2925_2933del(p.Glu976_Glu978del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.0000458 in 1,551,784 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000048 ( 0 hom. )
Consequence
LOXHD1
NM_001384474.1 inframe_deletion
NM_001384474.1 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.64
Genes affected
LOXHD1 (HGNC:26521): (lipoxygenase homology PLAT domains 1) This gene encodes a highly conserved protein consisting entirely of PLAT (polycystin/lipoxygenase/alpha-toxin) domains, thought to be involved in targeting proteins to the plasma membrane. Studies in mice show that this gene is expressed in the mechanosensory hair cells in the inner ear, and mutations in this gene lead to auditory defects, indicating that this gene is essential for normal hair cell function. Screening of human families segregating deafness identified a mutation in this gene which causes DFNB77, a progressive form of autosomal-recessive nonsyndromic hearing loss (ARNSHL). Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP3
Nonframeshift variant in repetitive region in NM_001384474.1
BP6
Variant 18-46560210-CTCCTCCTCT-C is Benign according to our data. Variant chr18-46560210-CTCCTCCTCT-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 505089.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LOXHD1 | NM_001384474.1 | c.2925_2933del | p.Glu976_Glu978del | inframe_deletion | 19/41 | ENST00000642948.1 | NP_001371403.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LOXHD1 | ENST00000642948.1 | c.2925_2933del | p.Glu976_Glu978del | inframe_deletion | 19/41 | NM_001384474.1 | ENSP00000496347 | P1 | ||
LOXHD1 | ENST00000536736.5 | c.2925_2933del | p.Glu976_Glu978del | inframe_deletion | 19/40 | 5 | ENSP00000444586 | |||
LOXHD1 | ENST00000441551.6 | c.2599-2730_2599-2722del | intron_variant | 5 | ENSP00000387621 | |||||
LOXHD1 | ENST00000335730.6 | n.2238_2246del | non_coding_transcript_exon_variant | 12/27 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
4
AN:
152180
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000566 AC: 9AN: 158876Hom.: 0 AF XY: 0.0000837 AC XY: 7AN XY: 83626
GnomAD3 exomes
AF:
AC:
9
AN:
158876
Hom.:
AF XY:
AC XY:
7
AN XY:
83626
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000479 AC: 67AN: 1399604Hom.: 0 AF XY: 0.0000594 AC XY: 41AN XY: 690300
GnomAD4 exome
AF:
AC:
67
AN:
1399604
Hom.:
AF XY:
AC XY:
41
AN XY:
690300
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74332
GnomAD4 genome
AF:
AC:
4
AN:
152180
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 22, 2017 | Variant classified as Uncertain Significance - Favor Benign. The p.Glu976_Glu978 del variant in LOXHD1 has now been identified by our laboratory in the heterozyg ous state in 2 individuals with hearing loss, neither of whom had a variant affe cting the other copy of the LOXHD1 gene. This variant is located within a polygl utamic acid tract that consists of 8 glutamic acid (Glu) residues in the human r eference genome, and results in an in-frame deletion of 3 glutamic acids (Glu) r esidues. This variant has been identified in 7/73148 European chromosomes and a similar variant resulting the same amino acid change has been identified in 48/2 2822 (0.2%) of South Asian chromosomes including 1 homozygote by the Genome Aggr egation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs765944082 an d rs753461629). The variant is not predicted to alter the reading frame of the p rotein and the polyglutamic acid tract region where the variant occurs is poorly conserved across species, suggesting that the variant may be tolerated; however , this information is not sufficient to rule out pathogenicity. In summary, whil e the clinical significance of the p.Glu976_Glu978del variant is uncertain, avai lable data suggest that it is more likely to be benign. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 13, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at